Trans4mMED – Transformative Patient Centred Personalised Medicine Initiative is a large-scale scientific and technological Future Emerging Technologies (FET) Flagship proposal that will address the grand challenge of developing regenerative, precision and personalized medicine to improve the quality of life of billions of patients worldwide.
The proposal is coordinated by the University of Minho, and is supported by a Steering Committee of 15 members, including the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, representing academia and industry leaders from across Europe. It is also supposed by a large number of organisations, including over 140 academia and health institutes, 40 research institutes, 95 industry and associations and 25 regional and national authorities.
Through a multi-actor and multi-disciplinary approach, the initiative will focus on the development of targeted and specific therapies for diseases that have an impact on society and the patient, the development of new technologies, and preventive and predictive tools.
FET Flagships are one of the most prestigious, highly-funded, strongest and game-changing instruments of EU research. They will involve a total budget of about €1 billion including EU and public and private funding.